Manyan kamfanoni 15 masu haɓaka kayan aikin likita a cikin 2023

labarai

Manyan kamfanoni 15 masu haɓaka kayan aikin likita a cikin 2023

Kwanan nan, kafofin watsa labarai na ketare Fierce Medtech sun zaɓi mafi kyawun sabbin abubuwa 15kamfanonin na'urorin likitancia cikin 2023. Waɗannan kamfanoni ba wai kawai suna mai da hankali kan fa'idodin fasaha na yau da kullun ba, har ma suna amfani da hankalinsu don gano ƙarin buƙatun likita.

01
Aikin tiyata
Samar da likitocin fiɗa da hangen nesa na ainihin lokaci

CEO: Manisha Shah-Bugaj
An kafa: 2017
Ana cikin: Boston

Activ Surgical ya kammala aikin tiyata na mutum-mutumi na farko a duniya akan nama mai laushi.Kamfanin ya sami amincewar FDA don samfurin sa na farko, ActivSight, tsarin tiyata wanda ke sabunta bayanan hoto nan take.

Ana amfani da ActivSight kusan cibiyoyi goma sha biyu a Amurka don aikin tiyatar launin fata, thoracic da na bariatric, da kuma hanyoyin gama gari kamar cire gallbladder.An kuma yi prostatectomies da yawa na mutum-mutumi ta amfani da ActivSight.

02
Beta Bionics
Ciwon Kankara na Artificial Revolutionary

CEO: Sean Saint
An kafa: 2015
Location: Irvine, California

Tsarin isar da insulin ta atomatik duk fushi ne a cikin fasahar fasahar ciwon sukari.Tsarin, wanda aka fi sani da tsarin AID, an gina shi ne a kusa da wani algorithm wanda ke ɗaukar karatun glucose na jini daga mai saka idanu na glucose mai ci gaba, da kuma bayanai game da abubuwan da ake amfani da su na carbohydrate da matakan aiki, da kuma tsinkayar waɗannan matakan a cikin 'yan mintoci masu zuwa.Canje-canjen da za su iya faruwa a cikin famfo na insulin kafin daidaita fitar da famfon insulin don guje wa hyperglycemia da za a iya faɗi.

Wannan babbar hanyar fasaha ta haifar da abin da ake kira tsarin rufe madauki, ko pancreas, wanda aka ƙera don rage aikin hannu ga masu ciwon sukari.

Beta Bionics yana ɗaukar wannan burin gaba tare da fasahar iLet bionic pancreas.Tsarin iLet yana buƙatar shigar da nauyin mai amfani kawai, yana kawar da buƙatar ƙididdige ƙididdiga masu wahala na cin carbohydrate.

03
Kala lafiya
Maganin sawa kawai a duniya don rawar jiki

Kujeru: Kate Rosenbluth, Ph.D., Deanna Harshbarger
An kafa: 2014
Ana zaune a: San Mateo, California

Marasa lafiya masu mahimmancin rawar jiki (ET) sun daɗe ba su da tasiri, ƙananan jiyya.Marasa lafiya kawai za su iya yin aikin tiyatar ƙwaƙwalwa mai ɓarna don saka na'urar motsa kwakwalwa mai zurfi, sau da yawa tare da tasiri mai sauƙi kawai, ko ƙayyadaddun magunguna waɗanda kawai ke magance alamun amma ba tushen tushen ba, kuma na iya haifar da mummunan sakamako.

Farawa na Silicon Valley Cala Health ya haɓaka na'urar da za a iya sawa don mahimmancin rawar jiki wanda zai iya isar da jiyya na neuromodulation ba tare da karya fata ba.

Na'urar Cala ONE na kamfanin FDA ta fara amincewa da ita a cikin 2018 don kawai maganin jiyya mai mahimmanci.Lokacin rani na ƙarshe, Cala ONE ya ƙaddamar da tsarin sa na gaba tare da izinin 510 (k): Cala kIQ™, na'urar farko da FDA ta amince da ita wacce ke ba da ingantacciyar maganin hannu ga marasa lafiya masu mahimmancin rawar jiki da cutar Parkinson.Na'urar da za a iya sawa don maganin jinyar girgiza.

04
Dalili
Neman Likitan Juyin Juya Hali

CEO: Yiannis Kiachopoulos
An kafa: 2018
Yana cikin: London

Causaly ya haɓaka abin da Kiachopoulos ya kira "matakin farko na samarwa AI co-pilot" wanda ke baiwa masana kimiyya damar hanzarta neman bayanai.Kayan aikin AI za su yi tambayoyi gabaɗayan binciken nazarin halittu da aka buga kuma su ba da cikakkun amsoshi ga hadaddun tambayoyi.Wannan kuma yana taimaka wa kamfanoni masu haɓaka magunguna su sami ƙarin tabbaci a cikin zaɓin da suke yi, kamar yadda abokan ciniki suka san kayan aiki zai ba da cikakken bayani game da yankin cutar ko fasaha.
Abu na musamman game da Causaly shine kowa zai iya amfani da shi, har ma da ma'aikata.
Mafi mahimmanci, masu amfani ba dole ba ne su karanta kowace takarda da kansu.

Wani fa'idar amfani da Causaly shine gano abubuwan da zasu iya haifar da illa ta yadda kamfanoni zasu iya kawar da maƙasudi.
05
Element Biosciences
Kalubalanci triangle mai yiwuwa na inganci, farashi da inganci

CEO: Molly He
An kafa: 2017
Yana cikin: San Diego

Tsarin Aviti na kamfanin zai fara farawa a farkon 2022. A matsayin na'ura mai girman tebur, yana ƙunshe da sel guda biyu masu gudana waɗanda za su iya aiki da kansu, suna rage farashin jeri.Aviti24, wanda ake sa ran zai fara halarta a cikin rabin na biyu na wannan shekara, an tsara shi don samar da haɓakawa ga injinan da aka shigar a halin yanzu da kuma juya su zuwa jerin kayan aikin da za su iya tantancewa ba kawai DNA da RNA ba, har ma da sunadarai da tsarin su, da kuma ilimin halittar sel. .

 

06
Kunna allurai
Gudanarwar cikin jijiya kowane lokaci, ko'ina

CEO: Mike Hooven
An kafa: 2010
Ana cikin: Cincinnati

A matsayin kamfanin fasahar likitanci fiye da shekaru goma a cikin samarwa, Enable Injections yana samun ci gaba kwanan nan.

Wannan faɗuwar, kamfanin ya karɓi na'urar da aka yarda da ita ta farko ta FDA, na'urar injectable EMPAVELI, wanda aka ɗora tare da Pegcetacoplan, farkon C3 da aka yi niyya don magance PNH (paroxysmal nocturnal hemoglobinuria).Pegcetacoplan shine magani na farko da FDA ta amince da shi don 2021. C3-niyya far don maganin PNH kuma shine magani na farko a duniya da aka amince don magance atrophy macular geographic.

Yarda da ita shine ƙarshen aikin shekaru na kamfanin akan na'urorin isar da magunguna waɗanda aka tsara don zama abokantaka masu haƙuri yayin ba da izinin sarrafa ƙwayar cuta mai yawa.

 

07
Exo
Wani sabon zamanin duban dan tayi na hannu

CEO: andeep Akkaraju
An kafa: 2015
Ana zaune a: Santa Clara, California

Exo Iris, na'urar duban dan tayi ta hannu wanda Exo ya ƙaddamar a cikin Satumba 2023, an yaba da shi a matsayin "sabon zamanin duban dan tayi" a lokacin, kuma an kwatanta shi da bincike na hannu daga kamfanoni kamar GE Healthcare da Butterfly Network.

Binciken na hannu na Iris yana ɗaukar hotuna tare da hangen nesa mai digiri 150, wanda kamfanin ya ce zai iya rufe hanta gaba ɗaya ko tayin zuwa zurfin santimita 30.Hakanan zaka iya canzawa tsakanin tsararraki mai lankwasa, madaidaiciya ko tsarin lokaci, alhali tsarin duban dan tayi na gargajiya yawanci yana buƙatar bincike daban.

 

08
Farawa Therapeutics
AI Pharmaceutical Rising Star

Shugaba: Evan Feinberg
An kafa: 2019
Ana zaune a: Palo Alto, California

Haɗa koyan injuna da hankali na wucin gadi cikin haɓaka magunguna babban yanki ne na saka hannun jari ga masana'antar biopharmaceutical.
Genesus yana da niyyar yin hakan ne da dandalin GEMS, ta hanyar amfani da wani sabon shiri da masu kafa kamfanin suka gina don tsara kananan kwayoyin halitta, maimakon dogaro da shirye-shiryen da ba na sinadari ba.

Dandali na Genesus Therapeutics' GEMS (Binciken Farawa na Molecular Space) yana haɗa nau'ikan tsinkaya na tushen ilmantarwa mai zurfi, kwaikwaiyon kwayoyin halitta da ƙirar harshe na fahimtar sinadarai, da fatan ƙirƙirar ƙananan ƙwayoyin ƙwayoyin cuta "na farko a aji" tare da matuƙar ƙarfi da zaɓi., musamman don yin niyya a baya waɗanda ba za a iya magance su ba.

 

09
Zuciyar Zuciya
Shugaban FFR

CEO: John Farquhar
An kafa: 2010
Ana zaune a: Mountain View, California

HeartFlow jagora ce a cikin Rarraba Flow Reserve (FFR), shirin da ke rarraba 3D CT angiography na zuciya don gano plaque da toshewar jijiyoyin jijiyoyin jini.

Ta hanyar ba da hangen nesa na kwararar jini na oxygenated zuwa tsokar zuciya da ƙididdigewa a fili a fili wuraren da ke tattare da tasoshin jini, kamfanin ya kafa hanyar keɓancewa don tsoma baki a cikin ɓoyayyun yanayin da ke haifar da dubun-dubatar ciwon ƙirji da bugun zuciya a kowace shekara Dalilan baya. lokuta masu kamawa.

Burinmu na ƙarshe shine mu yi don cututtukan zuciya da jijiyoyin jini abin da muke yi don ciwon daji tare da gwajin farko da magani na musamman, taimaka wa likitoci su yanke shawara bisa ga bukatun kowane majiyyaci.

 

10
Karius
Yaki da cututtukan da ba a sani ba

CEO: Alec Ford
An kafa: 2014
Ana zaune a: Redwood City, California

Gwajin Karius sabuwar fasaha ce ta ruwa wacce za ta iya gano ƙwayoyin cuta sama da 1,000 daga zana jini ɗaya cikin sa'o'i 26.Gwajin na iya taimaka wa likitocin su guje wa kamuwa da cuta da yawa, rage lokacin juyawa, da kuma guje wa jinkirin jinyar marasa lafiya a asibiti.

 

11
Linus Biotechnology
1cm gashi don gano autism

Shugaba: Dr. Manish Arora
An kafa: 2021
Ana zaune a: North Brunswick, New Jersey

StrandDx na iya hanzarta aikin gwaji tare da kayan gwaji na gida wanda ke buƙatar kawai zaren gashin da za a mayar da shi ga kamfani don sanin ko za a iya kawar da autism.

 

12
Namida Lab
Allon hawaye na cutar kansar nono

CEO: Omid Moghadam
An kafa: 2019
Ana zaune a: Fayetteville, Arkansas

Auria ita ce gwajin gwajin cutar kansar nono na farko da ke tushen hawaye a gida wanda ba hanyar bincike ba ne saboda baya bayar da sakamakon binaryar da ke nuna ko ciwon nono yana nan.Madadin haka, ƙungiyoyin suna haifar da nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan furotin guda biyu kuma suna ba da shawarar ko mutum ya nemi ƙarin tabbaci a cikin mammogram da wuri-wuri.

 

13
Nuhu Likitan
huhu biopsy nova

CEO: Zhang Jian
An kafa: 2018
Ana zaune a: San Carlos, California

Nuhu Medical ya tara dala miliyan 150 a shekarar da ta gabata don taimakawa tsarinta na sarrafa hoto na Galaxy gasa tare da ƙwararrun masana'antu guda biyu, dandamalin Ion Intuitive Surgical da kuma Johnson & Johnson's Monarch.

Dukkanin kayan aikin guda uku an tsara su azaman siririyar bincike wanda macizai ke shiga cikin lungu da sako na huhu, suna taimaka wa likitocin tiyata don neman raunuka da nodules da ake zargi da ɓoye ciwace-ciwacen daji.Koyaya, Nuhu, a matsayin marigayi, ya sami amincewar FDA a cikin Maris 2023.

A watan Janairun wannan shekara, tsarin kamfanin na Galaxy ya kammala cak na 500th.
Babban abu game da Nuhu shi ne cewa tsarin yana amfani da sassan da za a iya zubar da su gaba daya, kuma kowane bangare da ya shiga hulɗa da majiyyaci za a iya watsar da shi kuma a maye gurbinsa da sababbin kayan aiki.

 

14
Procyrion
Karkatar da maganin cututtukan zuciya da koda

Babban Jami'in Gudanarwa: Eric Fain, MD
An kafa: 2005
Yana cikin: Houston

A wasu mutanen da ke fama da gazawar zuciya, ana samun madaidaicin amsa mai suna Cardional Syndrome, wanda raunin zuciya tsokoki suka fara raguwa a cikin ikonsu na share ruwa daga jiki lokacin da raunin zuciya tsokoki suka kasa ɗaukar jini da iskar oxygen zuwa koda.Wannan tarin ruwa, bi da bi, yana ƙara nauyin bugun zuciya.

Procyrion yana nufin katse wannan ra'ayi tare da famfon Aortix, ƙaramin na'urar tushen catheter wanda ke shiga cikin aorta na jiki ta fata kuma ta ƙasa ta kirji da ciki.

Aiki kama da wasu bututun zuciya na tushen impeller, sanya shi a tsakiyar daya daga cikin manyan arteries na jiki lokaci guda yana sauƙaƙa wasu nauyin aiki akan zuciya ta sama kuma yana sauƙaƙe kwararar jini zuwa kodan.

 

15
Proprio
Ƙirƙiri taswirar tiyata

CEO: Gabriel Jones
An kafa: 2016
Ana zaune a: Seattle

Paradigm, wani kamfani na Proprio, shine dandamali na farko don amfani da fasahar filin haske da basirar wucin gadi don samar da hotunan 3D na ainihi na jikin mutum a lokacin tiyata don tallafawa aikin tiyata.


Lokacin aikawa: Maris 28-2024